Thank you for Subscribing to CIO Applications Weekly Brief

Signant Collaborates With Loftware To Develop Adaptive Investigational Product Labeling
Signant Health, the industry leader in evidence creation for contemporary clinical trials, has collaborated with Loftware to provide clients with comprehensive clinical trial supply labeling and packaging capabilities. L
By
CIO Applications | Thursday, August 25, 2022

Signant's end-to-end clinical supply management solutions are strengthened by the collaboration, as are the complicated production and distribution models inherent in current clinical research.
Fremont, CA: Signant Health, the industry leader in evidence creation for contemporary clinical trials, has collaborated with Loftware to provide clients with comprehensive clinical trial supply labeling and packaging capabilities. Loftware is a major provider of labeling and regulated content solutions. Their solutions can now be linked with Signant's SmartSignals Supplies solutions to enable clients with a streamlined product label design, approval, and manufacturing process.
Modern clinical trials allow accurate, efficient label printing and production processes to safeguard patient safety and avoid costly delays in study operations in an industry undergoing rapid transformation due to new study design and trial conduct models, as well as regular changes to the regulatory landscape.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
The collaboration with Loftware enables Signant clients to benefit from increased regulatory control, direct booklet label design/print, and the progression of in-line camera label verification as the industry transitions to a 'just-in-time' labeling strategy.
"In response to demand, we are partnering with Signant to offer customers an integrated solution to streamline the clinical supply labeling print processes. This will enable Signant customers who conduct traditional and decentralized clinical trials globally, a flexible, accurate, and compliant label production process that can adapt in real-time to changing circumstances," said Simon Jones, Vice President of Product Management for Loftware Life Sciences.
"We've seen explosive growth in direct-to-site and direct-to-patient clinical trial supply models, as well as requests for just-in-time packaging to accommodate advanced medicinal products," added Oliver Cunningham, Vice President of Supplies Management Solutions at Signant. "Loftware's industry-leading labeling capabilities, integrated with our SmartSignals Supplies solution and user workflows, offers customers the agility needed to maximize performance and compliance of their clinical supplies."
The firms' partnership streamlines and speeds clinical supply management by converting package lists from Signant's supplies software into print-ready, precise, and complete compliance labeling.
More in News

